LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001126049.2:c.-535_-534insC
KLLN
· NP_001119521.1:p.?
· NM_001126049.2
GRCh37: chr10:89622778 A>AG
·
GRCh38: chr10:87863021 A>AG
Gene:
KLLN
Transcript:
NM_001126049.2
Final call
VUS
PM2 supporting
BP4 supporting
Variant details
Gene
KLLN
Transcript
NM_001126049.2
Protein
NP_001119521.1:p.?
gnomAD AF
ClinVar
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): the 5' untranslated region insertion is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0 population reference datasets.
2
BP4 (Supporting): SpliceAI maximum delta score 0.022 is below the 0.1 threshold, predicting no significant splice impact.
3
Overall classification: VUS - the conflicting PM2 (supporting) and BP4 (supporting) evidence meets no ACMG/AMP 2015 Pathogenic or Benign combination threshold.
Final determination:
Under the generic ACMG/AMP 2015 fallback, PM2 supporting plus BP4 supporting is a conflicting one-supporting-pathogenic/one-supporting-benign combination that defaults to VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: the insertion lies in the 5' untranslated region upstream of the coding sequence, leaving the encoded protein unchanged. |
pvs1_variant_assessment
|
| PS1 | N/A | Not applicable: this is a noncoding 5' insertion with no amino-acid change (p.(=)), so there is no missense to compare with known pathogenic changes. |
|
| PS2 | Not assessed | Not assessed: no de novo occurrence with confirmed maternity/paternity and absence of the variant in both parents is documented. |
|
| PS3 | Not assessed | Not assessed: no validated functional assay result for this specific insertion was available. |
|
| PS4 | Not assessed | Not assessed: no case series, case-control comparison, or enrichment statistic for this exact insertion was available. |
|
| PM1 | N/A | Not applicable: the variant is upstream of the coding sequence, so no amino-acid residue exists to evaluate against functional domains or hotspots. |
|
| PM2 | Met | Met (supporting): the variant is absent from gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada v1.0 population reference datasets. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | Not assessed | Not assessed: no affected-proband observations, phase data, or co-occurring pathogenic alleles were identified. |
|
| PM4 | N/A | Not applicable: the 5' untranslated region insertion leaves the protein unchanged (p.(=)) and does not alter protein length. |
pvs1_variant_assessment
|
| PM5 | N/A | Not applicable: not a missense variant, so there is no amino-acid residue at which an alternate pathogenic missense could be compared. |
|
| PM6 | Not assessed | Not assessed: no suspected de novo occurrence without confirmed parental testing is documented. |
|
| PP1 | Not assessed | Not assessed: no affected relatives, familial genotypes, or phenotype-segregation data were identified. |
|
| PP2 | N/A | Not applicable: intended for missense variants in genes where missense is a common disease mechanism; this is a noncoding insertion. |
|
| PP3 | Not met | Not met: SpliceAI maximum delta 0.022 does not exceed the >0.2 PP3 threshold. |
spliceai
generic_acmg_combination_rules
|
| PP4 | Not assessed | Not assessed: no phenotype or clinical information for the carrier was provided, so phenotype specificity cannot be evaluated. |
|
| PP5 | Not met | Not met: the exact variant is absent from ClinVar, so no expert-panel pathogenic assertion exists to support it. |
clinvar
|
| BA1 | Not met | Not met: the variant is absent from population databases, so no allele frequency exceeds the stand-alone benign threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: the variant is absent from population datasets, so no allele frequency exceeds the benign threshold for the relevant disorder. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS2 | Not assessed | Not assessed: no unaffected adult carriers or unaffected homozygotes with phenotype information were identified. |
|
| BS3 | Not assessed | Not assessed: no validated functional study demonstrating a normal effect of this variant was available. |
|
| BS4 | Not assessed | Not assessed: no variant-carrying family members or informative non-segregation observations were documented. |
|
| BP1 | N/A | Not applicable: intended for missense variants in genes where truncation is the established mechanism; this is a noncoding insertion. |
|
| BP2 | Not assessed | Not assessed: no phase observations or co-occurring pathogenic variants were identified to establish a trans/cis relationship. |
|
| BP3 | N/A | Not applicable: applies to in-frame coding indels in repeat regions; this 5' insertion leaves the protein unchanged (p.(=)). |
pvs1_variant_assessment
|
| BP4 | Met | Met (supporting): SpliceAI maximum delta 0.022 falls below the 0.1 BP4 threshold, predicting no significant splice impact. |
spliceai
generic_acmg_combination_rules
|
| BP5 | Not assessed | Not assessed: no alternative causal diagnosis was documented to determine whether another finding explains the phenotype. |
|
| BP6 | Not met | Not met: the exact variant is absent from ClinVar, so no expert-panel benign assertion exists to support it. |
clinvar
|
| BP7 | N/A | Not applicable: reserved for synonymous coding variants; this is a 5' untranslated region insertion, not a synonymous change. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.